TGFB1 and renal fibrosis: A ramipril therapy that mainly targets the renin‒angiotensin‒aldosterone system (RAAS) to ameliorate AS-related kidney arterial hypertension effectively reduces TGFβ levels and thereby inhibits renal fibrosis (Gross et al. 2003), suggesting an important role of TGFβ in renal fibrosis.